No retraction, correction or concern found when last checked on Oct 31, 2026.

Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations

David Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons and 11 more

Genome Medicine · 2018

Abstract

Electronic supplementary material. The online version of this article (10.1186/s13073-018-0531-8) contains supplementary material, which is available to authorized users.

References 28

1.
Weinstein I, Cancer B. Addiction to oncogenes--the Achilles heal of cancer. Science. 2002;297:63–4.
Not in our library10.1126/science.1073096
2.
Futreal PA, et al. A census of human cancer genes. Nat Rev Cancer. 2004;4:177-183.
Not in our library10.1038/nrc1299
3.
Tamborero D, et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep. 2013;3:2650.
Not in our library10.1038/srep02650
4.
Rubio-Perez C, et al. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell. 2015;27:382-396.
Not in our library10.1016/j.ccell.2015.02.007
5.
Lawrence MS, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505:495-501.
Not in our library10.1038/nature12912
6.
Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502:333-339.
Not in our library10.1038/nature12634
7.
Landrum MJ, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2015;44:D862-D868.
Not in our library10.1093/nar/gkv1222
8.
Ainscough BJ, et al. DoCM: a database of curated mutations in cancer. Nat Methods. 2016;13:806-807.
Not in our library10.1038/nmeth.4000
9.
Chakravarty D, et al. OncoKB: a precision oncology knowledge base. JCO Precis Oncol. 2017; 10.1200/PO.17.00011.
Not in our library10.1200/po.17.00011
10.
Huang L, et al. The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations. J Am Med Informatics Assoc. 2017;24:513-519.
Not in our library10.1093/jamia/ocw148
11.
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer · 2017
No notice
12.
Dienstmann R, et al. Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors. Cancer Discov. 2015;5:118-123.
Not in our library10.1158/2159-8290.cd-14-1118
13.
Petitjean A, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat. 2007;28:622-629.
Not in our library10.1002/humu.20495
14.
Hudson TJ, et al. International network of cancer genome projects. Nature. 2010;464:993-998.
Not in our library10.1038/nature08987
15.
Schroeder MP, et al. OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action. Bioinformatics. 2014;30:549–55.
Not in our library10.1093/bioinformatics/btu467
16.
Martelotto LG, et al. Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations. Genome Biol. 2014;15:484.
Not in our library10.1186/s13059-014-0484-1
17.
Analysis of protein-coding genetic variation in 60,706 humans · 2016
No notice
18.
Kato S, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A. 2003;100:8424-8429.
Not in our library10.1073/pnas.1431692100
19.
Dogruluk T, et al. Identification of variant-specific functions of PIK3CA by rapid phenotyping of rare mutations. Cancer Res. 2015;75:5341-5354.
Not in our library10.1158/0008-5472.can-15-1654
20.
Kim E, et al. Systematic functional interrogation of rare cancer variants identifies oncogenic alleles. Cancer Discov. 2016;2641:617-632.
Not in our library10.1158/2159-8290.cd-16-0160
21.
Berger AH, et al. High-throughput phenotyping of lung cancer somatic mutations. Cancer Cell. 2015; 10.1016/j.ccell.2016.06.022.
Not in our library10.1016/j.ccell.2016.06.022
22.
Global Alliance for Genomics and Health. A federated ecosystem for sharing genomic, clinical data. Science. 2016;352:1278–80.
Not in our library10.1126/science.aaf6162
23.
Zhou W, et al. TransVar: a multilevel variant annotator for precision genomics. Nat Methods. 2015;12:1002-1003.
Not in our library10.1038/nmeth.3622
24.
Juric D, et al. Phase I dose escalation study of taselisib (GDC-0032), an oral PI3K inhibitor, in patients with advanced solid tumors. Cancer Discov. 2017; 10.1158/2159-8290.CD-16-1080.
Not in our library10.1158/2159-8290.cd-16-1080
25.
Leijen S, et al. Phase II study of WEE1 inhibitor AZD1775 plus carboplatin in patientswith tp53-mutated ovarian cancer refractory or resistant to first-line therapy within 3 months. J Clin Oncol. 2016;34:4354-4361.
Not in our library10.1200/jco.2016.67.5942
26.
AACR Project GENIE. Powering Precision Medicine Through An International Consortium. Cancer Discov. 2017;7:818–31.
Not in our library10.1158/2159-8290.cd-17-0151
27.
A Landscape of Pharmacogenomic Interactions in Cancer · 2016
No notice
28.
OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations · 2016
No notice

Cited by papers we hold 15

Pan-cancer whole-genome comparison of primary and metastatic solid tumours · 2023
No notice
Challenges in describing the conformation and dynamics of proteins with ambiguous behavior · 2022
Not checked
The next-generation Open Targets Platform: reimagined, redesigned, rebuilt · 2022
No notice
CEN‐tools: an integrative platform to identify the contexts of essential genes · 2020
Not checked
Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model · 2020
Not checked
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer · 2020
No notice
Pan-cancer analysis of whole genomes · 2020
Corrected
SNPnexus: a web server for functional annotation of human genome sequence variation (2020 update) · 2020
No notice
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets · 2019
No notice
The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens · 2019
No notice
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact · 2019
No notice
Pan-cancer whole-genome analyses of metastatic solid tumours · 2019
No notice
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer · 2019
No notice
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer · 2019
No notice
Open Targets Platform: new developments and updates two years on · 2018
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.